Literature DB >> 25274229

Peripheral sympathetic nerve dysfunction in adolescent Japanese girls following immunization with the human papillomavirus vaccine.

Tomomi Kinoshita1, Ryu-Ta Abe, Akiyo Hineno, Kazuhiro Tsunekawa, Shunya Nakane, Shu-Ichi Ikeda.   

Abstract

OBJECTIVE: To investigate the causes of neurological manifestations in girls immunized with the human papillomavirus (HPV) vaccine.
METHODS: During the past nine months, 44 girls visited us complaining of several symptoms after HPV vaccination. Four patients with other proven disorders were excluded, and the remaining forty subjects were enrolled in this study.
RESULTS: The age at initial vaccination ranged from 11 to 17 years, and the average incubation period after the first dose of the vaccine was 5.47±5.00 months. Frequent manifestations included headaches, general fatigue, coldness of the legs, limb pain and weakness. The skin temperature examined in 28 girls with limb symptoms exhibited a slight decrease in the fingers (30.4±2.6 °C) and a moderate decrease in the toes (27.1±3.7 °C). Digital plethysmograms revealed a reduced height of the waves, especially in the toes. The limb symptoms of four girls were compatible with the Japanese clinical diagnostic criteria for complex regional pain syndrome (CRPS), while those in the other 14 girls were consistent with foreign diagnostic criteria for CRPS. The Schellong test identified eight patients with orthostatic hypotension and four patients with postural orthostatic tachycardia syndrome. The girls with orthostatic intolerance and CRPS commonly experienced transient violent tremors and persistent asthenia. Electron-microscopic examinations of the intradermal nerves showed an abnormal pathology in the unmyelinated fibers in two of the three girls examined.
CONCLUSION: The symptoms observed in this study can be explained by abnormal peripheral sympathetic responses. The most common previous diagnosis in the studied girls was psychosomatic disease. The social problems of the study participants remained unresolved in that the severely disabled girls stopped going to school.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25274229     DOI: 10.2169/internalmedicine.53.3133

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  33 in total

1.  Re: Proposed HPV vaccination syndrome is unsubstantiated.

Authors:  Manuel Martínez-Lavin
Journal:  Clin Rheumatol       Date:  2015-11-14       Impact factor: 2.980

Review 2.  Fibromyalgia and small fiber neuropathy: the plot thickens!

Authors:  Manuel Martínez-Lavín
Journal:  Clin Rheumatol       Date:  2018-09-20       Impact factor: 2.980

Review 3.  Suspected adverse effects after human papillomavirus vaccination: a temporal relationship.

Authors:  Shu-Ichi Ikeda; Akiyo Hineno; Kazuki Ozawa; Tomomi Kinoshita
Journal:  Immunol Res       Date:  2018-12       Impact factor: 2.829

4.  Comment on: "Safety of Human Papillomavirus Vaccines: An Updated Review".

Authors:  Manuel Martínez-Lavín
Journal:  Drug Saf       Date:  2018-05       Impact factor: 5.606

Review 5.  Safety of Human Papillomavirus Vaccines: An Updated Review.

Authors:  Anastasia Phillips; Cyra Patel; Alexis Pillsbury; Julia Brotherton; Kristine Macartney
Journal:  Drug Saf       Date:  2018-04       Impact factor: 5.606

Review 6.  Autonomic dysfunction and HPV immunization: an overview.

Authors:  Svetlana Blitshteyn; Louise Brinth; Jeanne E Hendrickson; Manuel Martinez-Lavin
Journal:  Immunol Res       Date:  2018-12       Impact factor: 2.829

7.  Involvement of chronic epipharyngitis in autoimmune (auto-inflammatory) syndrome induced by adjuvants (ASIA).

Authors:  Osamu Hotta; Ayaki Tanaka; Akira Torigoe; Kazuaki Imai; Norio Ieiri
Journal:  Immunol Res       Date:  2017-02       Impact factor: 2.829

8.  Hazard of complex regional pain syndrome following human papillomavirus vaccination among adolescent girls in the United States: a case-cohort analysis of insurance claims data.

Authors:  Nadja A Vielot; Sylvia Becker-Dreps
Journal:  Expert Opin Drug Saf       Date:  2019-11-08       Impact factor: 4.250

Review 9.  HPV vaccines: a controversial issue?

Authors:  A F Nicol; C V Andrade; F B Russomano; L L S Rodrigues; N S Oliveira; D W Provance
Journal:  Braz J Med Biol Res       Date:  2016-04-08       Impact factor: 2.590

Review 10.  Impact of 2-, 4- and 9-valent HPV vaccines on morbidity and mortality from cervical cancer.

Authors:  Rebecca Luckett; Sarah Feldman
Journal:  Hum Vaccin Immunother       Date:  2015-11-20       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.